The average 1-year price target for Express Scripts Holding Company (ESRX) - averaging the work of different analysts - reveals a mean PT of $68.63/share.
Express Scripts Holding Company insiders have bought a net of 4,682 shares during the past three months, which implies that the company's top executives have been feeling bullish about the stock's outlook. Baupost Group LLC MA bought a new stake in Express Scripts Holding during the first quarter valued at approximately $80,978,000.
The other 11, though not evenly; between analysts who think you should buy Express Scripts Holding Company versus those who think you should sell it. Dodge & Cox lifted its stake in shares of Express Scripts Holding by 25.7% in the 2nd quarter. It also reduced its holding in Ionis Pharmaceuticals Inc (Put) by 1,264 shares in the quarter, leaving it with 1,259 shares, and cut its stake in Sucampo Pharmaceuticals Inc (NASDAQ:SCMP). In the last ninety days, insiders have sold 5,641 shares of company stock worth $357,317. Hancock Holding Co. grew its holdings in Express Scripts Holding by 9.9% in the 1st quarter. Oppenheimer Holdings Inc. restated a "hold" rating on shares of Express Scripts Holding Company in a report on Tuesday, February 14th. A 8 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NASDAQ:SLM) or, if they already own its stock, sell it. Dodge & Cox now owns 36,188,517 shares of the company's stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares during the period.
Express Scripts Holding Company (NASDAQ:ESRX) slipped over -0.81% at $57.71, after hitting low of $57.56 in an intra-day trade. In looking the SMA 50 we see that the stock has seen a 7.56% while it has a distance of 9.21% from the 200 days simple moving average. The company has market cap of $5.53 billion. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $80.02.
Express Scripts Holding Company (NASDAQ:ESRX) operates in the Health Care Plans segment of the Healthcare sector. The company reported $1.73 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.71 by $0.02. Company's return on equity, which is really just the product of the company's profit margin, asset turnover, and financial leverage ratios, is 19.80%, which is better than the Health Care Plans industry average ROE. After posting $1.73 EPS for the previous quarter, Express Scripts Holding Company's analysts now forecast 9.83 % EPS growth. During the same period in the prior year, the business earned $1.57 EPS. Equities analysts anticipate that Express Scripts Holding Company will post $6.99 earnings per share for the current year.
In related news, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction on Friday, September 8th. The shares were sold at an average price of $61.48, for a total value of $71,501.24.
Institutional investors have also been busy with the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The shares were sold at an average price of $63.93, for a total transaction of $249,327.00. Following the sale, the vice president now owns 10,530 shares of the company's stock, valued at $664,758.90. The disclosure for this sale can be found here.
Express Scripts Holding Company (ESRX) has an annual dividend of $0, while its annual dividend yield is 0%.
COPYRIGHT VIOLATION WARNING: "Tekla Capital Management LLC Buys Shares of 84,500 Express Scripts Holding Company (ESRX)" was reported by Week Herald and is the property of of Week Herald. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of worldwide copyright legislation. Ontario - Canada-based Agf has invested 0.17% in Express Scripts Holding Company (NASDAQ:ESRX). Echo Global Logistics had 25 analyst reports since August 11, 2015 according to SRatingsIntel.
Among 12 analysts covering Spectranetics (NASDAQ:SPNC), 4 have Buy rating, 0 Sell and 8 Hold. The average 1-year price target for (SLM) reveals an average price target of $14.22 per share. Needham & Company LLC assumed coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They issued a "hold" rating on the stock. RBC Capital Markets maintained the shares of VIAB in report on Friday, August 7 with "Outperform" rating.
More notable recent Express Scripts Holding Company (NASDAQ:ESRX) news were published by: Benzinga.com which released: "Wall Street's M&A Chatter From October 10: SeaWorld, Johnson Controls, Express ..." on October 11, 2017, also Nasdaq.com with their article: "Is Express Scripts Holding (ESRX) a Great Stock for Value Investors?" published on September 26, 2017, Prnewswire.com published: "Express Scripts to Acquire eviCore healthcare; Accelerates Company's Shift to ..." on October 10, 2017. The company has an average rating of "Hold" and an average target price of $69.45.